Evidence map›Paper›PMID 29956571›Full record

ArticleAutophagy2018

Autophagic reliance promotes metabolic reprogramming in oncogenic KRAS-driven tumorigenesis.

H Helen Lin, Yiyin Chung, Chun-Ting Cheng, Ching Ouyang, Yong Fu, Ching-Ying Kuo, Kevin K Chi, Maryam Sadeghi, Peiguo Chu, Hsing-Jien Kung and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Autophagy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 55 citations in OpenAlex.

  1. Trial
  2. METTL1-mediated mOncogene · 2026
    Article
  3. Biomedicines · 2025
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Frontiers in immunology · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Mitophagy in Pancreatic Cancer.Frontiers in oncology · 2021
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

H Helen Lina Department of Diabetes and Metabolic Diseases Research.
Yiyin Chunga Department of Diabetes and Metabolic Diseases Research.
Chun-Ting Chenga Department of Diabetes and Metabolic Diseases Research.
Ching Ouyangb Center for Informatics.
Yong Fua Department of Diabetes and Metabolic Diseases Research.
Ching-Ying Kuoa Department of Diabetes and Metabolic Diseases Research.
Kevin K Chia Department of Diabetes and Metabolic Diseases Research.
Maryam Sadeghia Department of Diabetes and Metabolic Diseases Research.
Peiguo Chuc Shared Pathology Core.
Hsing-Jien Kungd Department of Biochemistry and Molecular Medicine , UC Davis Comprehensive Cancer Center , Sacramento , CA USA.
Chien-Feng Lie Department of Pathology , Chi-Mei Medical Center , Tainan , Taiwan.
Kirsten H Limesandf Department of Nutritional Sciences , University of Arizona , Tucson , AZ USA.
David K Anna Department of Diabetes and Metabolic Diseases Research.
Chi Mei Medical Center · TWCity of Hope · USUniversity of Arizona · USUniversity of California, Davis · US

Funding

Transgenic Mouse FacilityP30CA033572 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI XIWEI WU · 1985 to 2026
$86.3M
MOLECULAR PROGRAMMING OF SALIVARY GLAND GENE EXPRESSIONR01DE010742 · NIDCR · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ANN, DAVID K. · 1993 to 2013
$5.1M
Mechanisms for Salivary Tumor Epithelial-Mesenchymal TransitionsR01DE026304 · NIDCR · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI ANN, DAVID K., LIN, HER HELEN · 2016 to 2020
$2.1M
Functional restoration through salivary progenitor label retaining cellsR01DE023534 · NIDCR · UNIVERSITY OF ARIZONA · PI ANN, DAVID K., LIMESAND, KIRSTEN H · 2014 to 2018
$1.9M
FLOAT System to Study Salivary Gland Cancer InvasionR21DE027713 · NIDCR · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI ANN, DAVID K., LIN, HER HELEN · 2018 to 2019
$476k
Molecular Characterization of Autophagy in Salivary Gland TumorsR21DE023298 · NIDCR · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI ANN, DAVID K. · 2013 to 2014
$462k
NCI NIH HHS P30 CA033572NIDCR NIH HHS R01 DE010742NIDCR NIH HHS R01 DE023534NIDCR NIH HHS R01 DE026304NIDCR NIH HHS R21 DE023298NIDCR NIH HHS R21 DE027713
6 · The paper itself

Abstract

Defects in basal autophagy limit the nutrient supply from recycling of intracellular constituents. Despite our understanding of the prosurvival role of macroautophagy/autophagy, how nutrient deprivation, caused by compromised autophagy, affects oncogenic KRAS-driven tumor progression is poorly understood. Here, we demonstrate that conditional impairment of the autophagy gene Atg5 (atg5-KO) extends the survival of KRAS

Indexed as

AutophagyAnimalsAsparagineAspartate-Ammonia LigaseCarcinogenesisCell Line, TumorDisease Models, AnimalDisease ProgressionEnergy MetabolismHumansMetabolomicsMice, KnockoutMitochondriaMitochondrial DynamicsNeoplasm InvasivenessOxygen ConsumptionAsparagineAspartate-Ammonia LigaseHras protein, mouseKRAS protein, humanProto-Oncogene Proteins p21(ras)asparagineasparagine synthetaseautophagymetabolic reprogrammingMFFmitochondriaoncogenic KRAS

Identifiers

PMID29956571
PMCPMC6135591
OpenAlexW2810073779

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.